Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial

BACKGROUND: Antiretroviral prophylaxis may be a critical strategy to reduce periconception HIV transmission. Maximizing the benefit of periconception pharmacologic HIV risk-reduction requires an understanding of the links between pregnancy and adherence to this prevention strategy. METHODS: We asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthews, Lynn T., Sibeko, Sengeziwe, Mansoor, Leila E., Yende-Zuma, Nonhlanhla, Bangsberg, David R., Karim, Quarraisha Abdool
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589407/
https://www.ncbi.nlm.nih.gov/pubmed/23472071
http://dx.doi.org/10.1371/journal.pone.0056400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589407/
https://www.ncbi.nlm.nih.gov/pubmed/23472071
http://dx.doi.org/10.1371/journal.pone.0056400

Ejemplares similares